| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 20,250 | $30 | $526.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 34,050 | $10 | $374.6K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,250 | $30 | $314.5K |
| J0897 | Injection, denosumab, 1 mg | 4,620 | $20 | $83.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 730 | $100 | $69.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 770 | $90 | $66K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 1,140 | $20 | $24K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 150 | $120 | $18.6K |
| J7322 | Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg | 890 | $10 | $11.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 200 | $50 | $10.5K |